Publications

* Corresponding Author

2023

1. Mondal I, Fatima SW, Priya S, Sengupta S, Khare SK*, Kulshreshtha R* A novel method for anti-miR delivery using transglutaminase-based nanoflowers for cancer treatment. ACS Biomaterials Science and Engineering (Accepted, March, 2023) IF- 5.395

 

2. Ghosh S, Yadav AK, Rani S, Takkar S, Kulshreshtha R, Nandan B, Srivastava R. 3D Printed hierarchical porous poly(ɛ-­‐caprolactone) scaffolds from Pickering high internal phase emulsion templating. Langmuir, 2023 January, 39, 5, 1927–1946.  IF-­‐ 4.33

 

3. Agrawal M, Yadav AK, Takkar S, Kulshreshtha R, Nandan B, Srivastava R. Dual-­‐functionalized Pickering HIPE templated poly(ɛ-­‐caprolactone) scaffold for maxillofacial implants. International Journal of Pharmaceutics, 2023 January; 13;633:122611.  IF-­‐ 6.51

2022

4. Chatterjee A and Kulshreshtha R. Editorial: Role of epigenetic regulators in the initiation, progression, and metastasis of cancer. Front. Genet. 2022 13:978097. (Accepted) doi: 10.3389/fgene.2022.978097. IF- 4.77                                                                                            

5. Dandapath I, Gupta R, Singh J, Shukla N, Jha P, Sharma S, Suri A, Sharma MC, Suri V*, Sarkar C*, Kulshreshtha R*. Long non-coding RNA and mRNA co-expression networks reveal novel players in pleomorphic xanthoastrocytoma. Molecular Neurobiology, 59 (8), 5149-5167. IF- 5.68       

​

6. Singh J, Jha P, Dandpath I, Shukla N, Gupta R, Katiyar A, Sharma V, Mahajan S, Chaturvedi S, Ahuja A, Bhardwaj M, Saran R, Garg A, Sharma MC, Manjunath N, Suri A, Kulshreshtha R*, Sarkar C*, Suri V*. Gene expression-based profiling of pleomorphic xanthoastrocytoma highlights two prognostic subgroups. American Journal of Translational Research, 2022 Feb 15;14(2):1010-1023.   IF- 4.06]

​

7. Srivastava S, Makala H, Sharma V, Suri V, Sarkar C, Kulshreshtha R*. MED12 is overexpressed in glioblastoma patients and serves as an oncogene by targeting the VDR/BCL6/p53 axis, Cellular and Molecular Life Sciences 2022 Jan 29;79(2):104.     IF- 9.26            

 

8. Salim U, Kumar A, Kulshreshtha R*, Perumal V*. Biogenesis, characterization, and functions of mirtrons. Wiley Interdiscip Rev RNA. 2022 Jan;13(1):e1680.   IF-9.96                         

 

9. Yadav G, Kulshreshtha R*. Metastasis associated long non-coding RNAs in glioblastoma: Biomarkers and therapeutic targets. Journal of Cellular Physiology, 2022 Jan;237(1):401-420.       IF-6.51,                                                                                                                                              

2021

10. Janjua TI, Rewatkar P, Ahmed-Cox A, Saeed I, Mansfeld FM, Kulshreshtha R, Kumeria T, Ziegler DS, Kavallaris M, Mazzieri R, Popat A. Frontiers in the treatment of glioblastoma: Past, present and emerging. Adv Drug Deliv Rev. Apr;171:108-138.    IF- 17.87, Citation 25  

                                

11. Parfenyev S, Singh A, Fedorova O, Daks A, Kulshreshtha R*, Barlev R*. Interplay between p53 and non-coding RNAs in regulating EMT in breast cancer. Cell Death and Disease (NPG) 2021 Jan 4;12(1):17. IF- 9.68, Citations 10                                                                                                             

 

12. Takkar S, Sharma V, Ghosh S, Suri A, Sarkar C, Kulshreshtha R*. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS. Cellular Oncology (Dordr), 2021, Apr;44(2):433-451.  IF- 7.05                              

 

13. Vinchure OS, Whittemore K, Kushwah D, Blasco MA, Kulshreshtha R*. miR-490 suppresses telomere maintenance program and associated hallmarks in glioblastoma. Cell Mol Life Sci. 2021 Mar;78(5):2299-2314.                                                                                          IF- 9.26, Citations 7

 

14. Vinchure OS, Kulshreshtha R*. miR-490: A potential biomarker and therapeutic target in cancer and other diseases. J Cell Physiol. 2021 May;236(5):3178-3193.  IF- 6.51                        

 

15. Mondal I, Kulshreshtha R*. Potential of microRNA-based diagnostics and therapeutics in glioma: a patent review. Expert Opin Ther Pat. 2021, Jan;31(1):91-106. IF- 6.79                        

 

16. Srivastava S, Kulshreshtha R*. Insights into the regulatory role and clinical relevance of mediator subunit, MED12, in human diseases. J Cell Physiol. 2021, May, 236(5):3163-3177. IF-6.51

​​

​2020

17. Kumar P, Mondal I, Kulshreshtha R, Patra AK. Development of novel ruthenium(II)-arene complexes displaying potent anticancer effects in glioblastoma cells. Dalton Trans. 2020 Oct 6;49(38):13294-13310. doi: 10.1039/d0dt02167a.  IF- 4.56                              

 

18. Shukla A, Srivastava S, Darokar J, Kulshreshtha R*. HIF1α and p53 regulated MED30, a mediator complex subunit, is involved in regulation of glioblastoma pathogenesis and temozolomide resistance. Cellular and Molecular Neurobiology, 2020 Jul 23. doi: 10.1007/s10571-020-00920-4. IF- 5.046                                                          

 

19. Bisht G, Srivastava S, Kulshreshtha R, Sourirajan A, Baumler DJ, Dev K. Applications of red pigments from psychrophilic Rhodonellum psychrophilum GL8 in health, food and antimicrobial finishes on textiles. Process Biochemistry, 2020, 94, 15-29.   IF-4.88                     

​

2019

20. Jana A, Narula P, Chugh A*,Kulshreshtha R*. Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment. International Journal of Pharmaceutics, 2019, Dec 15; 572:118789.    IF-4.85                                                                                   

 

21. Vinchure OS, Sharma V, Tabasum S, Ghosh S, Singh RP, Sarkar C, Kulshreshtha R*. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas. International Journal of Cancer. 2019, 145 (5), 1254-1269.        IF-7.3                                       

​

2018

22. Nagpal N, Sharma S, Maji S, Thakur JK*, Kulshreshtha R*. Essential role of MED1 in the transcriptional regulation of ER-dependent oncogenic miRNAs in breast cancer. Scientific Reports Aug 7;8(1):11805.   IF-4.5             

 

23. Agrawal R, Ankita, Malgulwar PB, Sharma V, Sarkar C and Kulshreshtha R*. P53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment. International Journal of Cancer, 2018 May 1;142(9):1817-1828.    IF-7.3

​

2017

24. Samanta, A, Takkar S, Kulshreshtha R, Nandan B, Srivastava RK. Hydroxyapatite stabilized pickering emulsions of poly (ε-caprolactone) and their composite electrospun scaffolds. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2017, 533, 224-230.     IF- 3.99, Citations-10

​

25. Sharma S, Rajendran V, Kulshreshtha R*, Ghosh PC*. Enhanced Efficacy of anti-miR-191 Delivery through Stearylamine Liposome Formulation for the treatment of Breast Cancer Cells. International Journal of Pharmaceutics 2017 Sep 15;530(1-2):387-400. IF-4.85 

 

26. Sharma S, Nagpal N, Ghosh PC, Kulshreshtha R*. P53-miR-191-SOX4 regulatory loop affects apoptosis in breast cancer. RNA (CSHL Press). 2017 Aug;23(8):1237-1246. IF- 4.99 

 

27. Meena SN, Sharma S, Kulshreshtha R, Janarthanam MK, Ghadi SC. Antiproliferative activity and phytochemical analysis of methanol leaves extract of Grewia nervosa. Current Science, 2017, 113 (10), 1828-1830.   IF- 0.76                                                                                                               

 

28. Samanta A, Takkar S, Kulshreshtha R, Nandan B, Srivastava R. Facile fabrication of composite electrospun nano-fibrous matrices of poly(ε-caprolactone)–silica based Pickering emulsion. 2017, Langmuir Aug 15;33(32):8062-8069.       IF- 4.01                                                                

 

29. Aji Alex MR, Nehate C, Veeranarayanan S, Kumar DS, Kulshreshtha R, Koul V. Self assembled dual responsive micelles stabilized with protein for co-delivery of drug and siRNA in cancer therapy. Biomaterials. 2017 Apr 17;133:94-106.  IF- 10.25

                                                          

30. Samanta A, Takkar Sonam, Kulshreshtha R, Nandan B, Srivastava R. Nano-silver stabilized Pickering emulsions and their antimicrobial electrospun fibrous matrices. Biomedical Physics & Engineering Express. 2017, 3 , p. 35011.  IF- 1.1                                                              

 

31. Sharma V, Malgulwar PB, Purkait S, Patil V, Pathak P, Agarwal R, Kulshreshtha R, Mallick S, Julka PK, Suri A, Sharma BS, Suri V, Sharma MC, Sarkar C. Genome wide ChIP-seq analysis of EZH2 mediated H3K27me3 target gene profile highlights differences between low and high grade astrocytic tumors as well as identifies SLC25A23 as a novel prognostic marker in glioblastoma. Carcinogenesis. 2017 Feb 1;38(2):152-161. IF-5.33

​​

2016

32. Agrawal R, Dale TP, Zubaidi MA, Malgulwar PB, Forsyth NR*, Kulshreshtha R*. Pluripotent and multipotent stem cells display distinct hypoxic miRNA expression. PloS One, 2016 Oct 26;11(10):e0164976.   IF: 3.09                                                                                                      

33. Sharma S, Patnaik PK, Aronov S, Kulshreshtha R*. ApoptomiRs in breast cancer: basics to clinics. Frontiers in genetics, 2016, 7:175. IF: 4.14                                                             

 

34. Samanta A, Takkar S, Kulshreshtha R, Nandan B, Srivastava RK. Electrospun composite matrices of poly(ε-caprolactone)-montmorillonite made using tenside free Pickering emulsions. Mater Sci Eng C Mater Biol Appl. 2016 1;69:685-91.  IF- 3.42                                                

 

35. Pal J, Singh S, Sharma S, Kulshreshtha R, Nandan B, Srivastava RK. Emulsion electrospun composite matrices of poly (ε-caprolactone)-hydroxyapatite: Strategy for hydroxyapatite confinement and retention on fiber surface. Materials Letters 2016, 167, 288-296.   IF: 3.09                                                                                                                      

 

36. Sharma V, Purkait S, Takkar S, Malgulwar PB, Kumar A, Pathak P, Suri V,  Sharma MC, Suri A, Kale SS, Kulshreshtha R*,Chitra Sarkar*. Analysis of EZH2:micro-RNA network in low and high grade astrocytic tumors. Brain Tumor Pathology 2016 33(2):117-28.  IF: 3.52 

​

2015

37. Jha P, Agrawal R, Pathak P, Kumar A, Purkait S, Mallik S, Suri V, Chand Sharma M, Gupta D, Suri A, Sharma BS, Julka PK, Kulshreshtha R*, Sarkar C*. Genome-wide small noncoding RNA profiling of pediatric high-grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52 and delineates H3F3A and TP53 mutant-specific miRNAs and snoRNAs. International J Cancer. 2015 Nov 15;137(10):2343-53. IF: 6.5 

                                                                                                                                                                       

38.  Nagpal N, Ahmad HM, Chameettachal S, Sundar S, Ghosh S, Kulshreshtha R*.HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment. Scientific Reports, 2015 5:9650.  IF: 5.58

 

39. Alex MRA, Nagpal N, Kulshreshtha R and Koul V*. Synthesis and evaluation of cationically modified poly(styrene-alt-maleic anhydride) nanocarriers forintracellular gene delivery. RSC Adv. 2015, 5, 21931.      IF: 3.84                                                                                               

2014

 40. Agrawal R, Pandey P, Jha P, Dwivedi V, Sarkar C*, Kulshreshtha R*.Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing. BMC Genomics. 2014 Aug 17;15:686. IF: 4.4                                                                                                       

41. Nagpal N, Kulshreshtha R*. miR-191: an emerging player in disease biology. Front Genet. 2014 Apr 23;5:99. doi: 10.3389/fgene.2014.00099. eCollection 2014.  IF: 4.2 

 

42. Pal J, Sharma S, Sanwaria S, Kulshreshtha R, Nandan B, Srivastava RK. Conducive 3D porous mesh of poly(ε-caprolactone) made via emulsion electrospinning. Polymer (Ms. No. POLYMER-14-994). 2014  55 (16), 3970-3979,   IF: 3.74                                                                        

44. Ahmad HM, Muiwo P, Ramachandran S, Pandey P, Gupta YK, Kumar L, Kulshreshtha R, Bhattacharya A. miR-22 regulates expression of oncogenic Neuro-epithelial transforming gene 1, NET1. FEBS Journal, 2014,  Sep;281(17):3904-19.  IF: 4.25                             

 

2013

45. Saxena S, Tandon B, Sharma S, Chameettachal S, Ray P, Ray AR, Kulshreshtha R*. Combined miRNA and mRNA signature identifies key molecular players and pathways involved in Chikungunya virus infection in human cells. PloS One, Nov 21;8(11):e79886.  IF: 4.2                                

 

46. Vaz C, Ahmad HM, Bharti R, Pandey P, Kumar L, Kulshreshtha R, Bhattacharya A. Analysis of the microRNA transcriptome and expression of different isomiRs in human peripheral blood mononuclear cells. BMC Res Notes. 2013, Sep 28, 6:390. IF:1.39 

                    

47. Sharma S, Verma S, Vasudevan M, Samanta S, Thakur JK, Kulshreshtha R*. The interplay of HuR and miR-3134 in regulation of AU rich transcriptome. RNA Biology, 2013, Aug;10(8):1283-90. Featured as Key scientific Article in Global Medical Discovery Series (April 3, 201

 

48. Nagpal N, Ahmad HM, Molparia B, and Kulshreshtha R*. MicroRNA-191, an estrogen responsive microRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis. 2013 May 9. Featured in section “Cancer” in World Biomedical Frontiers (ISSN: 2328-0166):; Featured in MDLinx, 2013

 

2011

49. Srikantan S, Abdelmohsen K, Lee EK, Tominaga K, Subaran SS, Kuwano Y, Kulshrestha R, Panchakshari R, Kim HH, Yang X, Martindale JL, Marasa BS, Kim MM, Wersto RP, Indig FE, Chowdhury D, Gorospe M. Translational control of TOP2A influences doxorubicin efficacy. Mol Cell Biol. 2011 Sep;31(18):3790.   IF- 5.7

 

50. Moskwa P, Buffa FM, Pan Y, Panchakshari R, Vischioni B, Gottipati P, Abdelmohsen K, Camps C, Ragoussis J, Kulshreshtha R, Weinstock DM, Parker A, Pezzella F,  Gorospe M, Sharma RA, Helleday T, Harris AL, Chowdhury D. miR-182-mediated down-regulation of BRCA1 impacts on the DNA damage response and breast cancer therapy. Molecular Cell, 2011 Jan 21;41(2):210-20. IF - 14.9

 

2010

51. Vaz C, Ahmad HM, Sharma P, Gupta R, Kumar L, Kulshreshtha R, Bhattacharya A. Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood. BMC Genomics, 2010, 11:288.  IF-4.6                                                                                                 

2009

52. Fasanaro P, Greco S, Lorenzi M, Pescatori M, Brioschi M, Kulshreshtha R, Banfi C, Stubbs A, Calin GA, Ivan M, Capogrossi MC, Martelli F. An integrated approach for experimental target identification of hypoxia-induced mir-210. Journal of Biological Chemistry, 2009, 284:35134-43, IF– 4.65

 

53. Crosby M, Kulshreshtha R, Ivan M, Glazer PM. MicroRNA Regulation of DNA Repair Gene Expression in Hypoxic Stress. 2009. Cancer Research, 69:1221-9.     IF-9.28

 

2008

54. Ivan M, Harris AL, Martelli F, Kulshreshtha R. Hypoxia Response and microRNAs: No Longer Two Separate Worlds. 2008, Journal of Cellular and Molecular Medicine, 12:1426-31. IF- 4.75                                                                                                           

 

55. Kulshreshtha R, Davaluri R, Calin GA, Ivan M. A microRNA Component of the hypoxic response. 2008 Cell Death and Differentiation,15: 667-671.     IF- 8.38                                      

 

2007

56. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu C-G,Croce CM, Negrini M, Calin GA and Ivan M. A MicroRNA Signature of Hypoxia. 2007. Mol Cell Biol., 27: 1859-1867.   IF - 5.04   *Ranked among the top 5 papers in MCB.                                                                                                         ​

 

57. Kulshreshtha R, Ferracin M, Negrini M, Calin GA, Davuluri RV, Ivan M. Regulation of microRNA expression: the hypoxic component. 2007 Cell Cycle, 6:1426-1431.  IF- 5.01

 

58. Singh G, Jain M, Kulshreshtha R, Khurana JP, Kumar S, Singh P. Expression analysis of genes encoding translation initiation factor 3 subunit g (TaeIF3g) and vesicle-associated membrane protein-associated protein (TaVAP) in drought tolerant and susceptible cultivars of wheat. 2007. Plant Science.173, 660–669.    IF- 4.1